# EDGAR Filing Document

**Accession Number:** 0001494413
**File Stem:** 0001494413-26-000026
**Filing Date:** 2026-5
**Character Count:** 113089
**Document Hash:** 1b3786559e83aafcfb02f8ba13263453
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001494413-26-000026.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0001494413-26-000026

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 48

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260522

**DATE AS OF CHANGE**: 20260522

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Two Hands Corp
- **CENTRAL INDEX KEY:** 0001494413
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 334429767
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56065
- **FILM NUMBER:** 261012905

**BUSINESS ADDRESS:**
- **STREET 1:** 141 PIPING ROCK ROAD
- **CITY:** LOCUST VALLEY
- **STATE:** NY
- **ZIP:** 11560
- **BUSINESS PHONE:** 516-384-2577

**MAIL ADDRESS:**
- **STREET 1:** 141 PIPING ROCK ROAD
- **CITY:** LOCUST VALLEY
- **STATE:** NY
- **ZIP:** 11560

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TWO HANDS Corp
- **DATE OF NAME CHANGE:** 20160901

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Innovative Product Opportunities Inc.
- **DATE OF NAME CHANGE:** 20100616

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

OR

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to __________

Commission File Number: 333-167667

**TWO HANDS CORPORATION**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **33-4429767** |
| (State or Other Jurisdiction of | (I.R.S. Employer |
| Incorporation or Organization) | Identification No.) |
| <br> **141 Piping Rock Road<br> Locust Valley, New York**<br> (Address of Principal Executive Offices) | <br> **11560**<br> (Zip Code)<br>|

---

**(516) 384-8577**

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes⌧ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ◻ Accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ◻ <br> Non-accelerated filer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ⌧ Smaller reporting company&nbsp;&nbsp;&nbsp;&nbsp; ⌧ <br> Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ◻ No ⌧

 **Securities registered under Section 12(b) of the Act:**

Title of each class Name of each exchange on which registered <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A

**Securities registered under Section 12(g) of the Act:**

Common Stock, $.0001 Par Value

(Title of class)

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: As of May 12, 2026 the issuer had 6,633,882,467 shares of its common stock issued and outstanding, par value $0.0001 per share.

**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS**

This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed on April 14, 2026, and other filings we make with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.

The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with our audited financial statements and related notes thereto included in our Form 10-K filed on April 14, 2026.

**TWO HANDS CORPORATION**

**QUARTERLY REPORT ON FORM 10-Q**

**FOR THE QUARTER ENDED MARCH 31, 2026**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**PART I** |  | &nbsp;&nbsp;**PAGE** |
| &nbsp;&nbsp;**Item 1.** | &nbsp;&nbsp;**Financial Statements (Unaudited)** | &nbsp;&nbsp; **5** |
| &nbsp;&nbsp;**Item 2.** | &nbsp;&nbsp;**Management's Discussion and Analysis of Financial Condition and Results of Operations** | &nbsp;&nbsp; **18** |
| &nbsp;&nbsp;**Item 3.** | &nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk | &nbsp;&nbsp; **25** |
| &nbsp;&nbsp;**Item 4.** | &nbsp;&nbsp;Controls and Procedures | &nbsp;&nbsp; **26** |
| &nbsp;&nbsp;**PART II** |  |  |
| &nbsp;&nbsp;**Item 1.** | &nbsp;&nbsp;**Legal Proceedings** | &nbsp;&nbsp;**27** |
| &nbsp;&nbsp;**Item 1A.** | &nbsp;&nbsp;**Risk Factors** | &nbsp;&nbsp; 27 |
| &nbsp;&nbsp;**Item 2.** | &nbsp;&nbsp;**Unregistered Sales of Equity Securities and Use of Proceeds** | &nbsp;&nbsp; 27 |
| &nbsp;&nbsp;**Item 3.** | &nbsp;&nbsp;**Defaults Upon Senior Securities** | &nbsp;&nbsp; 27 |
| &nbsp;&nbsp;**Item 4.** | &nbsp;&nbsp;**Mining Safety Disclosures** | &nbsp;&nbsp; 27 |
| &nbsp;&nbsp;**Item 5.** | &nbsp;&nbsp;**Other Information** | &nbsp;&nbsp; 27 |
| &nbsp;&nbsp;**Item 6.** | &nbsp;&nbsp;**Exhibits** | &nbsp;&nbsp; **28** |
|  | &nbsp;&nbsp;**Signatures** | &nbsp;&nbsp; **29** |

---

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

---

| |
|:---|
| &nbsp;&nbsp;**TWO HANDS CORPORATION** |
| &nbsp;&nbsp;**CONDENSED CONSOLIDATED BALANCE SHEETS** |

---

---

| | | |
|:---|:---|:---|
|  | **March 31,<br> 2026** | **December 31,<br> 2025** |
|  | **(Unaudited)** | |
| ASSETS |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $47057 | $227585 |
| &nbsp;&nbsp;&nbsp;VAT taxes receivable | 22536 | 22057 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | 10844 | 4594 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 80437 | 254236 |
| Property and equipment, net | 3950 | 4392 |
| Deposits | 381887 | 60000 |
| Total assets | $466274 | $318628 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $570929 | $552612 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities - related party | 235417 | 192417 |
| &nbsp;&nbsp;&nbsp;Note payable - related party | 1136654 | 882632 |
| &nbsp;&nbsp;&nbsp;Notes payable | 117069 | 118978 |
| &nbsp;&nbsp;&nbsp;Non-redeemable convertible note, net - related party | 125918 | 120000 |
| &nbsp;&nbsp;&nbsp;Convertible promissory note, net | 22504 | 2598 |
| &nbsp;&nbsp;&nbsp;Derivative liabilities | 259166 | 395464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 2467657 | 2264701 |
| Total liabilities | 2467657 | 2264701 |
| Commitments and Contingencies |  |  |
| Stockholder's deficit |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock; $0.001 par value; 1,000,000 shares authorized, 0 issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Common stock; $0.0001 par value; 12,000,000,000 shares authorized, 6,501,509,691 and 6,501,509,691 shares issued and outstanding, respectively | 650152 | 650152 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 92324398 | 92324398 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 93303 | 84379 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (95069236) | (95005002) |
| &nbsp;&nbsp;&nbsp;Total stockholders' deficit | (2001383) | (1946073) |
| Total liabilities and stockholders' deficit | $466274 | $318628 |
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. |

---

---

| |
|:---|
| &nbsp;&nbsp;**TWO HANDS CORPORATION** |
| &nbsp;&nbsp;**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)** |
| &nbsp;&nbsp;**(Unaudited)** |

---

---

| | | |
|:---|:---|:---|
|  | **For the three months ended<br> March 31,** | **For the three months ended<br> March 31,** |
|  | **2026** | **2025** |
| Revenue | $— | $— |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative | 235686 | 257069 |
| Total operating expenses | 235686 | 257069 |
| Loss from operations | (235686) | (257069) |
| Other income (expense) |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of debt discount and interest expense | (44846) | (73363) |
| &nbsp;&nbsp;&nbsp;Initial derivative expense | (33804) |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of derivative liabilities | 250102 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other income (expense) | 171452 | (73363) |
| Net loss | (64234) | (330432) |
| Other comprehensive income (loss) |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 8924 | (3228) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | 8924 | (3228) |
| Comprehensive loss | $(55310) | $(333660) |
| Loss per common share - basic and diluted | $(0.00) | $(0.00) |
| Weighted average number of common shares outstanding - basic and diluted | 6501509691 | 5469037729 |
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. |

---

---

| |
|:---|
| &nbsp;&nbsp;**TWO HANDS CORPORATION** |
| &nbsp;&nbsp;**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT** |
| &nbsp;&nbsp;**For the three months ended March 31, 2026 and 2025** |
| &nbsp;&nbsp;**(Unaudited)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional Paid-in**<br> **Capital** | **Accumulated Other Comprehensive**<br> **Income (Loss)** | **Accumulated**<br> **Deficit** | **Total Stockholders'**<br>**Deficit** |
| **Balance, December 31, 2025** | 6501509691 | $650152 | $92324398 | $84379 | $(95005002) | $(1946073) |
| Foreign currency translation adjustment |  |  |  | 8924 |  | 8924 |
| Net loss |  |  |  |  | (64234) | (64234) |
| **Balance, March 31, 2026** | **6501509691** | $**650152** | $**92324398** | $**93303** | $**(95069236)** | $**(2001383)** |
|  | **Common Stock** | **Common Stock** | **Additional Paid-in** | **Accumulated Other Comprehensive** | **Accumulated** | **Total Stockholders'** |
|  | **Shares** | **Amount** | **Capital** | **Income (Loss)** | **Deficit** | **Deficit** |
| **Balance, December 31, 2024** | 5469037729 | $546905 | $90288032 | $116977 | $(94520148) | $(3568234) |
| Foreign currency translation adjustment |  |  |  | (3228) |  | (3228) |
| Net loss |  |  |  |  | (330432) | (330432) |
| **Balance, March 31, 2025** | **5469037729** | $**546905** | $**90288032** | $**113749** | $**(94850580)** | $**(3901894)** |
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. |

---

---

| |
|:---|
| &nbsp;&nbsp;**TWO HANDS CORPORATION** |
| &nbsp;&nbsp;**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** |
| &nbsp;&nbsp;**(Unaudited)** |

---

---

| | | |
|:---|:---|:---|
|  | **For the three months ended<br> March 31,** | **For the three months ended<br> March 31,** |
|  | **2026** | **2025** |
| Cash flows from operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(64234) | $(330432) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to cash used in operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 378 | 2605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bad debt |  | 6438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and interest expense | 44846 | 73363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Initial derivative expense | 33804 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of derivative liabilities | (250102) |  |
| &nbsp;&nbsp;&nbsp; Change in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and taxes receivable | (846) | 63104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expense | (6392) | (13081) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 68905 | 1997 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use liability |  | (2073) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (173641) | (198079) |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposits | (321887) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (321887) |  |
| Cash flow from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advances | 235000 | 1236 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of advances |  | (2075) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses paid for by related party |  | 199937 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of convertible promissory note, net | 80000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 315000 | 199098 |
| Net change in cash | (180528) | 1019 |
| Cash, beginning of the period | 227585 | 1733 |
| Cash, end of the period | $47057 | $2752 |
| Cash paid during the period |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid | $— | $— |
| The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. | The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements. |

---

**TWO HANDS CORPORATION**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited)

**NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION**

Two Hands Corporation (the "Company") was incorporated in the state of Delaware on April 3, 2009 and on July 26, 2016, changed its name from Innovative Product Opportunities Inc. to Two Hands Corporation.

The Two Hands co-parenting application launched on July 2018 and the Two Hands Gone application launched In February 2019. The Company ceased work on these applications in 2021.

The gocart.city online consumer grocery delivery application was released in early June 2020 and Cuore Food Services commenced sale of dry goods and produce to other businesses in July 2020.

In July 2021, the Company made the strategic decision to focus exclusively on the grocery market through three on-demand branches of its grocery businesses: gocart.city, Grocery Originals, and Cuore Food Services.

i) gocart.city is the Company's online delivery marketplace, allowing consumers to shop online and have their groceries delivered.

ii) Grocery Originals is the Company's brick-and-mortar grocery store located in Mississauga Ontario at the site of the Company's warehouse.

iii) Cuore Food Services is the Company's wholesale food distribution branch.

On May 1, 2024, the Company entered into an asset sale agreement with a non-related private corporation ("Purchaser") whereby the Company sold the assets of gocart.city. The sale included the e-commerce site, branding, supporting components of the Grocery Originals store and inventory. The ongoing sales and client bases of gocart.city and Grocery Originals were transferred as part of the asset sale. After May 1, 2024, the Company continued the business of Cuore Food Services.

In June 2025, the Company announced, after fully evaluating the legacy business, the Company is taking steps to reinvigorate it and establish a new pathway in the same business space. The Company will continue to evaluate opportunities both inside and outside the food industry, including, but not limited to, ventures within the fintech and gig economy spaces.

The Company received approval from the Canadian Securities Exchange (the "CSE") to list its common shares (the "Common Shares") on the CSE. Trading of the Common Shares in the capital of the Company commenced on August 5, 2022, under the symbol "TWOH".

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

BASIS OF PRESENTATION

The accompanying condensed consolidated financial statements of Two Hands Corporation have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission requirements for interim financial statements. Therefore, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2025 of Two Hands Corporation in our Form 10-K filed on April 10, 2026.

The interim financial statements present the balance sheets, statements of operations, stockholders' deficit and cash flows of Two Hands Corporation. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States.

The interim financial information is unaudited. In the opinion of management, all adjustments necessary to present fairly the financial position as of March 31, 2026 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year.

GOING CONCERN

The Company's financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. During the three months ended March 31, 2026, the Company incurred a net loss of $64,234 and used cash in operating activities of $173,641, and on March 31, 2026, had stockholders' deficit of $2,007,433 and an accumulated deficit of $95,069,236. These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date that the financial statements are issued. The Company will be dependent upon the raising of additional capital through placement of its common stock in order to implement its business plan. There can be no assurance that the Company will be successful in this situation. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might result from this uncertainty. We are currently funding our operations by way of cash advances from our Chief Executive Officer, note holders, shareholders and others; however, we do not have any oral or written agreements with them or others to loan or advance funds to us. There can be no assurances that we will be able to receive loans or advances from them or other persons in the future.

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Two Hands Canada Corporation and Meridian Capital Management Inc. All intercompany transactions and balances have been eliminated in consolidation.

USE OF ESTIMATES AND ASSUMPTIONS

Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS

For the purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

ACCOUNTS RECEIVABLE

Trade accounts receivable is recorded at the invoiced amount and do not bear interest. The Company grants credit to its customers with defined payment terms, performs ongoing evaluations of the credit worthiness of its customers and generally does not require collateral. Accounts receivables are carried at their outstanding principal amounts, less an anticipated amount for discounts and an allowance for expected credit losses, which management believes is sufficient to cover potential credit losses based on historical experience and periodic evaluation of the financial condition of the Company's customers. Estimated credit losses consider relevant information about past events, current conditions and reasonable and supporting forecasts that affect the collectability of financial assets.

The allowance for doubtful accounts on March 31, 2026 and December 31, 2025 is $141,870 and $144,184, respectively. As of March 31, 2026 and December 31, 2025, net accounts receivable is $0.

PROPERTY AND EQUIPMENT

Property and equipment is stated at cost, less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense when incurred, while renewals and betterments that materially extend the life of an asset are capitalized.

The costs of assets sold, retired, or otherwise disposed of, and the related allowance for depreciation, are eliminated from the accounts, and any resulting gain or loss is recognized in the results from operations. Depreciation is provided over the estimated useful lives of the assets, which are as follows:

Computer equipment 50% declining balance over a three year useful life

In the year of acquisition, one half the normal rate of depreciation is provided.

REVENUE RECOGNITION

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which we determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which we expect to be entitled in exchange for those goods or services. ASC 606 requires us to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, we satisfy the performance obligation. We recognize revenue for the sale of our products upon delivery to a customer.

DEBT DISCOUNT AND DEBT ISSUANCE COSTS

Debt discounts and debt issuance costs incurred in connection with the issuance of convertible notes are capitalized and amortized to interest expense based on the related debt agreements using the effective interest rate method. Unamortized discounts are netted against convertible notes.

DERIVATIVE LIABILITY

In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 815-10-25-1 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.

INCOME TAXES

The Company accounts for income taxes in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 740, Income Taxes. Under the assets and liability method of ASC 740, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

NET LOSS PER SHARE

Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On March 31, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 1,826,425,205 shares as their effect would have been anti-dilutive. On March 31, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and Series C Stock of 1,551,541,351 shares as their effect would have been anti-dilutive.

FOREIGN CURRENCY TRANSLATION

The consolidated financial statements are presented in United States dollars. The functional currency of the consolidated entities are determined by evaluating the economic environment of each entity. The functional currency of Two Hands Corporation is the United States dollar. Foreign exchange translation adjustments are reported as gains or losses resulting from foreign currency transactions and are included in the results of operations.

Two Hands Canada Corporation maintains its accounts in the Canadian dollar. Assets and liabilities are translated to United States dollars at year-end exchange rates. Income and expenses are transaction at averages exchange rate during the year. Foreign currency transaction adjustments are reported as other comprehensive income, a component of equity in the consolidated.

STOCK-BASED COMPENSATION

The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, Stock Compensation. Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.

FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

Included in the ASC Topic 820 framework is a three level valuation inputs hierarchy with Level 1 being inputs and transactions that can be effectively fully observed by market participants spanning to Level 3 where estimates are unobservable by market participants outside of the Company and must be estimated using assumptions developed by the Company. The Company discloses the lowest level input significant to each category of asset or liability valued within the scope of ASC Topic 820 and the valuation method as exchange, income or use. The Company uses inputs which are as observable as possible and the methods most applicable to the specific situation of each company or valued item.

The Company's financial instruments such as cash, accounts payable and accrued liabilities, non-redeemable convertible notes, notes payable and due to related parties are reported at cost, which approximates fair value due to the short-term nature of these financial instruments.

Derivative liabilities are measured at fair value on a recurring basis using Level 3 inputs.

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2025 on a recurring basis:

---

| | | | |
|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| <br>**Description** | **Level 1**<br>**$** | **Level 2**<br>**$** | **Level 3**<br>**$** |
| &nbsp;&nbsp;Derivative liabilities |  |  | 259166 |

---

RECENT ACCOUNTING PRONOUNCEMENTS

In October 2023, the FASB issued ASU No. 2023-06, *"Disclosure Improvements — Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative."* The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SEC's August 2018 final amendments in Release No. 33-10532, *Disclosure Update and Simplification* that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. Early adoption is permitted. The adoption of ASU 2023-06 is not expected to have a material impact on the Company's consolidated financial statements or related disclosures.

ASU 2024-03, *Disaggregation of Income Statement Expenses* ("ASU 2024-03"), requires public companies to disaggregate key expense categories, such as inventory purchases, employee compensation and depreciation in their financial statements. This aims to improve investor insight into company performance. ASU 2024-03 was originally effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.

ASU 2025-01, *Income Statement – Expense Disaggregation Disclosures – Clarifying the Effective Date* ("ASU 2025-01"), clarifies the effective date of ASU 2024-03. This amendment states that ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.

ASU 2025-05, *Financial Instruments-Credit Losses: Measurement of Credit Losses for Accounts Receivable and Contract Assets for Private Companies and Certain Not-for-profit Entities (PCC)* ("ASU 2025-05"), updates accounting standards for revenue from contracts with customers (ASC 606). ASU 2025-05 permits an entity to assume that current conditions as of the balance sheet date will not change for the remaining life of the asset when estimated expected credit losses, and an accounting policy election to consider subsequent cash-collection activity after the balance sheet date. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted this new standard on January 1, 2026 and the adoption did not have a material impact on the consolidated financial statements.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

**NOTE 3 – NON-REDEEMABLE CONVERTIBLE NOTE, NET – RELATED PARTY**

On September 13, 2018, the Company entered into a Side Letter Agreement ("Original Note") with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company's common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.

On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 resulting in a loss of extinguishment of $28,665.

Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.

The consolidated statement of operations includes amortization of debt discount of $5,918 and $4,932 for the three months ended March 31, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On March 31, 2026 and December 31, 2025, the carrying amount of the Note is $125,918 (face value of $144,000 less $18,082 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.

**NOTE 4 – NOTES PAYABLE**

As of March 31, 2026 and December 31, 2025, notes payable due to Piero Manzini and Nadav Elituv, the former CEO of the Company, totaling $117,069 and $118,978, respectively, were outstanding. The balances are non-interest bearing, unsecured and have no specified terms of repayment.

**NOTE 5 – CONVERTIBLE PROMISSORY NOTE, NET**

**Vanquish Funding Group, Inc.**

On November 13, 2025, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. ("Holder") relating to the issuance and sale of a Convertible Note (the "Note") with an original principal amount of $115,000 less original issue discount of $15,000 and transaction costs of $7,000 bearing an 10% annual interest rate and maturing August 15, 2026 for $93,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder's option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder's deposit fees associated with the conversion. The Company may prepay the Note in cash, if repaid within 90 days of date of issue, at 115% of the original principal amount plus interest, between 91 days and 150 days at 120% of the original principal amount plus interest and between 151 days and 180 days at 125% of the original principal amount plus interest. On March 31, 2026 and December 31, 2025, the Note was recorded at amortized cost of $12,547 (comprised of principal of $115,000 plus accrued interest of $4,348 less debt discount of $106,801) and $1,849 (comprised of principal of $115,000 plus accrued interest of $1,513 less debt discount of $114,664), respectively.

On December 2, 2025, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. ("Holder") relating to the issuance and sale of a Convertible Note (the "Note") with an original principal amount of $94,300 less original issue discount of $12,300 and transaction costs of $7,000 bearing an 10% annual interest rate and maturing September 15, 2026 for $75,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder's option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder's deposit fees associated with the conversion. The Company may prepay the Note in cash, if repaid within 90 days of date of issue, at 115% of the original principal amount plus interest, between 91 days and 150 days at 120% of the original principal amount plus interest and between 151 days and 180 days at 125% of the original principal amount plus interest. On March 31, 2026 and December 31, 2025, the Note was recorded at amortized cost of $6,790 (comprised of principal of $94,300 plus accrued interest of $3,074 less debt discount of $90,584) and $750 (comprised of principal of $94,300 plus accrued interest of $749 less debt discount of $94,299).

On January 16, 2026, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. ("Holder") relating to the issuance and sale of a Convertible Note (the "Note") with an original principal amount of $100,050 less original issue discount of $13,050 and transaction costs of $7,000 bearing an 10% annual interest rate and maturing October 15, 2026 for $80,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder's option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder's deposit fees associated with the conversion. The Company may prepay the Note in cash, if repaid within 90 days of date of issue, at 115% of the original principal amount plus interest, between 91 days and 150 days at 120% of the original principal amount plus interest and between 151 days and 180 days at 125% of the original principal amount plus interest. On March 31, 2026 the Note was recorded at amortized cost of $3,167 (comprised of principal of $100,050 plus accrued interest of $2,028 less debt discount of $98,911).

**NOTE 6 - DERIVATIVE LIABILITY**

The Convertible Promissory Notes with Vanquish Funding Group, Inc. with the issue dates of November 13, 2025, December 2, 2025 and January 16, 2026 is accounted for under ASC 815. The variable conversion price is not considered predominantly based on a fixed monetary amount settleable with a variable number of shares due to the volatility and trading volume of the Company's common stock. The Company's derivative liabilities have been measured at fair value using the binomial model.

The inputs into the binomial models are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**March 31,**<br> **2026** | &nbsp;&nbsp;**January 16,**<br> **2026** | &nbsp;&nbsp;**December 31,**<br> **2025** | &nbsp;&nbsp;**December 2,**<br> **2025** | &nbsp;&nbsp;**November 13,**<br> **2025** |
| &nbsp;&nbsp;Closing share price | &nbsp;&nbsp;$0.0012 | &nbsp;&nbsp;$0.0017 | &nbsp;&nbsp;$0.0016 | &nbsp;&nbsp;$0.0011 | &nbsp;&nbsp;$0.0024 |
| &nbsp;&nbsp;Conversion price | &nbsp;&nbsp;$0.0008 | &nbsp;&nbsp;$0.0011 | &nbsp;&nbsp;$0.0007 | &nbsp;&nbsp;$0.0008 | &nbsp;&nbsp;$0.0013 |
| &nbsp;&nbsp;Risk free rate | &nbsp;&nbsp;3.70% | &nbsp;&nbsp;3.70% | &nbsp;&nbsp;4.29% | &nbsp;&nbsp;3.90% | &nbsp;&nbsp;3.90% |
| &nbsp;&nbsp;Expected volatility | &nbsp;&nbsp;154% - 193% | &nbsp;&nbsp;234% | &nbsp;&nbsp;227% | &nbsp;&nbsp;258% | &nbsp;&nbsp;256% |
| &nbsp;&nbsp;Dividend yield | &nbsp;&nbsp;0% | &nbsp;&nbsp;0% | &nbsp;&nbsp;0% | &nbsp;&nbsp;0% | &nbsp;&nbsp;0% |
| &nbsp;&nbsp;Expected life | &nbsp;&nbsp;0.38 - 0.54 years | &nbsp;&nbsp;0.75 years | &nbsp;&nbsp;0.62 - 0.71 years | &nbsp;&nbsp;0.79 years | &nbsp;&nbsp;0.75 years |

---

The fair value of the convertible promissory note derivative liability relating to the Note issued to Vanquish Funding Group, Inc. on January 16, 2026 is $113,804, of which $80,000 was recorded as a debt discount and the remainder of $33,804 was recorded as initial derivative expense. The decrease in the fair value of the conversion option derivative liability of $250,102 is recorded as a gain in the consolidated statements of operations for the three months ended March 31, 2026. The convertible promissory note derivative liability on March 31, 2026 and December 31, 2025 is $259,166 and $395,464, respectively.

**NOTE 7 – RELATED PARTY TRANSACTIONS**

**Notes payable – related party**

On March 31, 2026 and December 31, 2025, $1,136,654 (comprising of $1,088,100 of advances and $48,554 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive.

During three months ended March 31, 2026, the Company issued total advances for $235,000 comprising $235,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable – related party earns interest at 8% per annum, is unsecured and is due on demand.

**Employment Agreements**

During the three months ended March 31, 2026 and 2025, compensation expenses of $79,500 and $55,000, respectively, was incurred for the Chief Executive Officer, Chief Financial Officer, and a Director.

**NOTE 8 - STOCKHOLDERS' EQUITY**

The Company is authorized to issue an aggregate of 12,000,000,000 common shares with a par value of $0.0001 per share and 1,000,000 shares of preferred stock with a par value of $0.0001 per share.

**Preferred Stock**

On August 6, 2013, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating two hundred thousand (200,000) shares as Series A Convertible Preferred Stock ("Series A Stock"). Each share of Series A Stock is convertible into one thousand (1,000) shares of common stock of the Company. On April 21, 2022, the Company amended its articles to amend the terms of its Series A Convertible Preferred Stock to become non-voting shares. Previously Series A Stock were entitled to the number of votes equal to the aggregate number of shares of common stock into which the Holder's share of Series A Stock is convertible, multiplied by one hundred (100).

On December 12, 2019, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating one hundred thousand (100,000) shares as Series B Convertible Preferred Stock ("Series B Stock"). After a one year holding period, each share of Series B Stock is convertible into one thousand (1,000) shares of common stock of the Company. Series B Stock is non-voting.

On October 7, 2020, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating five thousand (5,000) shares as Series C Convertible Preferred Stock, par value $0.001 per share ("Series C Stock"). Each share of Series C Stock (i) has a liquidation value of $100, subject to various anti-dilution protections (ii) is convertible into shares of common stock of the Company six months after the date of issuance at a price of $0.25 per share effective June 30, 2022, subject to various anti-dilution protections (iii) on conversion will receive an aggregate number of shares of common stock as is determined by dividing the liquidation value by the conversion price. Series C Stock are non-voting. On June 24, 2021, the board of directors approved the increase in the number of designated shares of Series C Convertible Preferred Stock from 5,000 to 30,000 and reduction of the conversion price from $0.0035 per share to $0.002 per share. On April 27, 2022, a 1 for 1,000 reverse stock split of the Company's common stock took effect which increased the conversion rate from $0.002 per share to $2.00 per share. On June 30, 2022, the Company made an amendment to the Certificate of Designation of its Series C Stock which lowered the fixed conversion price from $2.00 per share to $0.25 per share.

On September 1, 2021, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating two hundred thousand (200,000) shares as Series D Convertible Preferred Stock, par value $0.001 per share ("Series D Stock"). Each share of Series D Stock is convertible into one hundred (100) shares of common stock of the Company six months after the date of issuance. Series D Stock are non-voting.

On June 30, 2022, the Company made an amendment to the Certificate of Designation of its Series C Stock which lowered the fixed conversion price from $2.00 per share to $0.25 per share. Per separate agreement, the fixed conversion price was adjusted to $400 per share. The Company accounted for the amendment as an extinguishment and recorded a deemed dividend in accordance with ASC 260-10-S99-2.

On October 4, 2022, the Company filed a Certificate of Designation with the Delaware Secretary of State that had the effect of designating 300,000 shares of preferred stock as Series E Convertible Preferred Stock ("Series E Stock"). Series E Stock are non-voting, have a par value of $0.0001 per share and have a stated value of $1.00 per share. Each share of Series E Stock carries an annual cumulative dividend of 10% of the stated value. The Company may redeem Series E Stock in cash, if redeemed within 60 days of issuance date, at 110% of the stated value plus accrued unpaid dividends and between 61 days and 180 days at 115% of the stated value plus unpaid accrued dividends. After 180 days of the issuance date, the Company does not have the right to redeem Series E Stock. After 180 days after the issue date, Series E Stock at the stated value together with any unpaid accrued dividends are convertible into shares of common stock of the Company at the Holder's option at a variable conversion price calculated at 75% of the market price defined as the lowest three average trading price during the ten trading day period ending on the latest trading day prior to the conversion date. After 18 months following the issuance date, the Company must redeem for cash Series E Stock at its stated value plus any accrued unpaid dividends and the default adjustment, if any.

**NOTE 9 – COMMITMENTS**

On July 14, 2025, the Company entered into a definitive agreement with More Capital Ltd. The purpose of the definitive agreement is to incorporate a new holding company to operate a confection brand and operating company The definitive agreement includes conditions precedent for the Company to issue 40,000,000 shares of its common stock to More Capital Ltd. and for the Company to transfer $65,000 of cash to More Capital Ltd. As of the date of these financial statements, the shares have not been issued and cash has not been paid pursuant to the terms of this agreement.

On July 28, 2025, the Company entered into a definitive agreement with More Money Ltd. The definitive agreement provides that More Money Ltd. will receive 110,000,000 shares of the Company's common stock and the Company will transfer $200,000 of cash to More Money Ltd. The CEO transferred 110,000,000 personal shares to satisfy the equity portion of the consideration, and the Company advanced $120,000 and $60,000 in cash at March 31, 2026 and December 31, 2025, respectively. As the full amount of cash due has not yet been transferred, the $120,000 and $60,000 is recorded as a deposit on the consolidated balance sheet at March 31, 2026 and December 31, 2025, respectively.

**Deposits on asset acquisition**

On January 23, 2026, the Company entered into an agreement with OnGraph Technologies Limited and/or its affiliates, including DailyLove (collectively "DailyLove") whereby DailyLove agreed to provide the Company with (i) a license in 100% of the intellectual property (including all software, source code, data, models and documentation) assets related to the AI dating platform (DAILYLOVE.AI) (the" IP Assets") and (ii) issue a certain number of shares of common stock of DailyLove, all pursuant to terms and conditions of this agreement ("Equity Contingency Consideration").

In consideration of the IP Assets the Company agreed to pay to DailyLove $500,000 in cash in three installments as follows (i) $125,000 on January 23, 2026 (ii) $125,000 on February 5, 2026 and (iii) $250,000 on February 28, 2026. Upon payment of each installment of cash consideration the Company will receive Equity Contingency Consideration as follows (i) upon payment of the first installment, 2.25% of the total issued and outstanding shares of DailyLove ("DL Shares") (ii) upon payment of the second installment, 2.25% of the total issued and outstanding DL Shares and (iii) upon payment of the third installment, 4.5% of the total issued and outstanding DL Shares.

As of March 31, 2026, the Company recorded Deposits of $261,887 on the balance sheet comprising cash paid to DailyLove of $250,000 and an introductory fee of $11,887 paid to a consultant. None of the Equity Contingency Consideration has been received and the final cash installment of $250,000 has not yet been paid as of the date of these financial statements. Once the terms of the agreement have been fulfilled, we expect to report this transaction as a cost method investment.

**NOTE 10 – SUBSEQUENT EVENTS**

On April 7, 2026, the 77,627,224 shares of common stock of the Company was returned to treasury and cancelled.

On April 30, 2026, the Company agreed to issued 160,000,000 shares of common stock of the Company for consulting services.

On May 6, 2026, the Company agreed to issued 50,000,000 shares of common stock of the Company for corporate advisory and communication services.

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The Company received approval from the Canadian Securities Exchange (the "CSE") to list its common shares (the "Common Shares") on the CSE. Trading of the Common Shares in the capital of the Company commenced on August 5, 2022, under the symbol "TWOH".

**Cuore Food Services**

Cuore Food Services is the Company's wholesale food distribution branch. Cuore Food Services uses inventory from the Company's warehouse as well as inventory it acquires on an ad hoc basis, and focuses on bulk delivery of goods to food service business such as restaurants, hotels, event planning/hosting businesses.

**Management's Plan of Operation** 

In June 2025, the Company announced, after fully evaluating the legacy business, the Company is taking steps to reinvigorate it and establish a new pathway in the same business space. The Company will continue to evaluate opportunities both inside and outside the food industry, including, but not limited to, ventures within the fintech and gig economy spaces.

**Critical Accounting Policies and Estimates**

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Financial Statements and accompanying notes. Estimates are used for, but not limited to, the accounting for the allowance for doubtful accounts, inventories, impairment of long-term assets, stock-based compensation, derivatives, income taxes and loss contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies, among others, may be impacted significantly by judgment, assumptions and estimates used in the preparation of the Financial Statements:

NET LOSS PER SHARE

Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On March 31, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 1,826,425,205 shares as their effect would have been anti-dilutive. On March 31, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and Series C Stock of 1,551,541,351 shares as their effect would have been anti-dilutive.

STOCK-BASED COMPENSATION

The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, Stock Compensation. Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.

DERIVATIVE LIABILITY

In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 815-10-25-1 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.

RECENT ACCOUNTING PRONOUNCEMENTS

In October 2023, the FASB issued ASU No. 2023-06, *"Disclosure Improvements — Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative."* The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SEC's August 2018 final amendments in Release No. 33-10532, *Disclosure Update and Simplification* that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. Early adoption is permitted. The adoption of ASU 2023-06 is not expected to have a material impact on the Company's consolidated financial statements or related disclosures.

ASU 2024-03, *Disaggregation of Income Statement Expenses* ("ASU 2024-03"), requires public companies to disaggregate key expense categories, such as inventory purchases, employee compensation and depreciation in their financial statements. This aims to improve investor insight into company performance. ASU 2024-03 was originally effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.

ASU 2025-01, *Income Statement – Expense Disaggregation Disclosures – Clarifying the Effective Date* ("ASU 2025-01"), clarifies the effective date of ASU 2024-03. This amendment states that ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.

ASU 2025-05, *Financial Instruments-Credit Losses: Measurement of Credit Losses for Accounts Receivable and Contract Assets for Private Companies and Certain Not-for-profit Entities (PCC)* ("ASU 2025-05"), updates accounting standards for revenue from contracts with customers (ASC 606). ASU 2025-05 permits an entity to assume that current conditions as of the balance sheet date will not change for the remaining life of the asset when estimated expected credit losses, and an accounting policy election to consider subsequent cash-collection activity after the balance sheet date. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted this new standard on January 1, 2026 and the adoption did not have a material impact on the consolidated financial statements.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

COMPARISON OF RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025

**Operating expenses:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $ | $% | % |
| &nbsp;&nbsp;Salaries and benefits | 79500 | 55000 | 24500 |  | 44 |
| &nbsp;&nbsp;Occupancy expense |  | 1254 | (1254) |  | (100) |
| &nbsp;&nbsp;Advertising and travel | 1134 |  | 1134 |  |  |
| &nbsp;&nbsp;Auto expenses |  | 340 | (340) |  | (100) |
| &nbsp;&nbsp;Consulting | 43933 | 5954 | 37979 |  | 638 |
| &nbsp;&nbsp;Depreciation and Amortization | 377 | 2605 | (2228) |  | (86) |
| &nbsp;&nbsp;Bad debt |  | 6438 | (6438) |  | (100) |
| &nbsp;&nbsp;Office and general expenses | 25272 | 19784 | 5488 |  | 28 |
| &nbsp;&nbsp;Professional fees | 85470 | 165694 | (80224) |  | (48) |
| &nbsp;&nbsp;Freight and delivery |  |  |  |  |  |
| &nbsp;&nbsp;Total operating expenses | 235686 | 257069 | (21383 |  | (8) |

---

Our total operating expenses for the three months ended March 31, 2026 was $235,686, compared to $257,069, for the three months ended March 31, 2025, respectively. The decrease in total operating expense is primarily due to decrease in professional fees, offset by an increase in salaries and benefits.

Salaries and benefits for the three months ended March 31, 2026 and 2025, comprise primarily compensation of our officers and directors of $79,500 and $55,000, respectively.

During the three months ended March 31, 2026 and 2025, consulting expenses of $43,933 and $5,954 consisted of costs related to the development of new businesses and bookkeeping services.

Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.

**Other income (expense):**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $ | $% | % |
| &nbsp;&nbsp;Amortization of debt discount and interest expense | (44846) | (73363) | 28517 |  | (39) |
| &nbsp;&nbsp;Initial derivative expense | (33804) |  | (33804) |  |  |
| &nbsp;&nbsp;Change in fair value of derivative liability | 250102 |  | 250102 |  |  |
| &nbsp;&nbsp;Total other income (expenses) | 171452 | (73363) | 238765 |  | (325) |

---

Amortization of debt discount and interest expense for the three months ended March 31, 2026 was $44,846, compared to $73,363 for the three months ended March 31, 2025. Amortization of debt discount and interest expense relates to the issuance of non-redeemable convertible notes, convertible notes and promissory notes.

Initial derivative expense of $33,804 for the three months ended March 31, 2026 represents the difference between the fair value of the total embedded derivative liability of $113,804 and the cash received of $80,000 for convertible note issued on January 16, 2026.

During the three months ended March 31, 2026 and 2025, the gain due to the change in fair value of derivative liabilities was $250,102 and $0, respectively.

**Net loss for the period:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $% | % |
| &nbsp;&nbsp;Net loss for the period | (64234) | (330432) |  | (79) |

---

Our net loss for the three months ended March 31, 2026 was $64,234, compared to $330,432 for the three months ended March 31, 2025, respectively. Our losses during the three months ended March 31, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, professional fees, interest, offset by an decrease in fair value of derivative liabilities.

QUARTERLY RESULTS OF OPERATIONS

The following is a summary of selected quarterly information that has been derived from the financial statements of the Company. This summary should be read in conjunction with the consolidated financial statements of the Company.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Quarter Ended** | &nbsp;&nbsp;**March 31, 2026** | &nbsp;&nbsp;**December 31, 2025** | &nbsp;&nbsp;**September 30, 2025** | &nbsp;&nbsp;**June 30, 2025** | &nbsp;&nbsp;**March 31, 2025** | &nbsp;&nbsp;**December 31, 2024** | &nbsp;&nbsp;**September 30, 2024** | &nbsp;&nbsp;**June 30, 2024** |
| &nbsp;&nbsp;**Sales** | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$140258 | &nbsp;&nbsp;$179502 | &nbsp;&nbsp;$226289 |
| &nbsp;&nbsp;**Gross profit** | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;$- | &nbsp;&nbsp;($34216) | &nbsp;&nbsp;$26025 | &nbsp;&nbsp;$45010 |
| &nbsp;&nbsp;**Operating expenses** | &nbsp;&nbsp;($235686) | &nbsp;&nbsp;($332678) | &nbsp;&nbsp;($259977) | &nbsp;&nbsp;($207602) | &nbsp;&nbsp;($257069) | &nbsp;&nbsp;($299791) | &nbsp;&nbsp;($300665) | &nbsp;&nbsp;($311499) |
| &nbsp;&nbsp;**Other income (expense)** | &nbsp;&nbsp;$171452 | &nbsp;&nbsp;$930910 | &nbsp;&nbsp;($156359) | &nbsp;&nbsp;($128716) | &nbsp;&nbsp;($73363) | &nbsp;&nbsp;($489659) | &nbsp;&nbsp;($58477) | &nbsp;&nbsp;($228552) |
| &nbsp;&nbsp;**Net income (loss) for the period** | &nbsp;&nbsp;($64234) | &nbsp;&nbsp;$598232 | &nbsp;&nbsp;($416336) | &nbsp;&nbsp;($336318) | &nbsp;&nbsp;($330432) | &nbsp;&nbsp;($823666) | &nbsp;&nbsp;($333117) | &nbsp;&nbsp;($495041) |
| &nbsp;&nbsp;**Basic and diluted net income (loss) per share** | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) | &nbsp;&nbsp;($0.00) |

---

LIQUIDITY AND CAPITAL RESOURCES

**For the three months ended March 31, 2026**

**Cash flows used in operating activities**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $% | % |
| &nbsp;&nbsp;Net cash used in operating activities | (173641) | (198079) |  | (12) |

---

Our net cash used in operating activities for the three months ended March 31, 2026 and 2025 is $173,641 and $198,079, respectively. Our net loss for the three months ended March 31, 2026 of $70,284 and change in fair value of derivative liabilities of $250,102 was the main contributing factors for our negative cash flow. We were able to partially offset the cash used in operating activities with non-cash expenses such as amortization of debt discount and initial derivative expense.

**Cash flows used in investing activities**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $ | $% |
| &nbsp;&nbsp;Net cash used in investing activities | (321887) |  | (321887) |  |

---

**Cash flows from financing activities**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended March 31, | Three months ended March 31, | Change | Change |
|  | 2026<br> $ | 2025<br> $ | $% | % |
| &nbsp;&nbsp;Net cash used in financing activities | 315000 | 199098 |  | 58 |

---

Our net cash provided by financing activities for the three months ended March 31, 2026 and 2025, is $315,000 and $199,098, respectively.

During the three months ended March 31, 2026 and 2025, the Company received cash advances from related party of $235,000 and $199,098, respectively. These cash advances earns interest at 8% per annum, is unsecured and is due on demand.

As of March 31, 2026, we had cash of $47,057, working capital (deficiency) of $(2,387,220) and total liabilities of $2,467,657.

Our working capital as of March 31, 2026 and December 31, 2025 is as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31,<br> 2026** | **December 31,<br> 2025** |
| &nbsp;&nbsp;Current assets | $80437 | $254236 |
| &nbsp;&nbsp;Current liabilities | 2467657 | 2264701 |
| &nbsp;&nbsp;Working capital (Deficiency) | $(2387220) | $(2010465) |

---

The Company is continuing to focus improving cash flows from operations by reducing incentives to customers, by making purchases from different suppliers, accelerating the collection of accounts receivable, reducing expenses, managing accounts payable balances and by paying our officers, directors, consultants and staff with our stock.

The Company's financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. During the three months ended March 31, 2026, the Company incurred a net loss of $64,234 and used cash in operating activities of $173,641, and on March 31, 2026, had stockholders' deficit of $2,007,433 and an accumulated deficit of $95,069,236 These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued. The Company's independent registered public accounting firm, in their report on the Company's financial statements for the year ended December 31, 2025, contains an explanatory paragraph regarding the Company's ability to continue as a going concern. The Company's financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.

Over the next 12 months we expect to spend approximately $300,000 in cash for operations, legal, accounting and related services and to implement our business plan. We hope to be able to compensate our independent contractors with stock-based compensation, which will not require us to use our cash, although there can be no assurances that we will be successful in these efforts.

---

| | |
|:---|:---|
|  | **Cash Required to Implement of Business Plan** |
| &nbsp;&nbsp;General and Administration | $300000 |
| &nbsp;&nbsp;**Total Estimated Cash Expenditures** | $300000 |

---

We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink.. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.

The inability to obtain financing or generate sufficient cash from operations could require us to reduce or eliminate expenditures for developing products and services, or otherwise curtail or discontinue our operations, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, to the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If we raise additional funds through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of our common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuing stock in lieu of cash, which may also result in dilution to existing stockholders.

Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol "TWOH".

Commitments for future capital expenditures at March 31, 2026 is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** |
| **Contractual obligations** | Total <br>$ | Less than 1 year <br>$ | 1 - 3 years<br> $ | 4 – 5 years<br> $ | After 5 years<br> $ |
| &nbsp;&nbsp;Accounts payable and accrued liabilities | 806346 | 806346 |  |  |  |
| &nbsp;&nbsp;Debt | 1253723 | 1253723 |  |  |  |
| &nbsp;&nbsp;Non-redeemable convertible notes | 125918 | 125918 |  |  |  |
| &nbsp;&nbsp;Convertible promissory note | 22504 | 22504 |  |  |  |
| &nbsp;&nbsp;Derivative liability | 259166 | 259166 |  |  |  |
| &nbsp;&nbsp;Operating leases |  |  |  |  |  |
| &nbsp;&nbsp;Total contractual obligations | 2467657 | 2467657 |  |  |  |

---

OPERATING CAPITAL AND CAPITAL EXPENDITURE REQUIREMENTS

We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.

Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol "TWOH".

RELATED PARTY TRANSACTIONS

**Three months ended March 31, 2026 and 2025**

**Non-redeemable Convertible Notes – Related Party**

On September 13, 2018, the Company entered into a Side Letter Agreement ("Original Note") with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company's common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.

On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 (see Note 7) resulting in a loss of extinguishment of $28,665.

Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.

The consolidated statement of operations includes amortization of debt discount of $5,918 and $4,932 for the three months ended March 31, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On March 31, 2026 and December 31, 2025, the carrying amount of the Note is $125,918 (face value of $144,000 less $18,082 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.

**Promissory Notes – Related Party**

On March 31, 2026 and December 31, 2025, $1,136,654 (comprising of $1,088,100 of advances and $48,554 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive. During three months ended March 31, 2026, the Company issued total advances for $235,000 comprising $235,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable – related party earns interest at 8% per annum, is unsecured and is due on demand.

Our policy with regard to transactions with related persons or entities is that such transactions must be on terms no less favorable than could be obtained from non-related persons.

The above related party transactions are not necessarily indicative of the amounts that would have been incurred had a comparable transaction been entered into with an independent party. The terms of these transactions were more favorable than would have been attained if the transactions were negotiated at arm's length.

PROPOSED TRANSACTIONS

The Company is not anticipating any transactions.

CHANGES IN ACCOUNTING POLICIES INCLUDING INITIAL ADOPTION

Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on accounting policies.

FINANCIAL INSTRUMENTS

The main risks of the Company's financial instrument are exposed to are credit risk, market risk, foreign exchange risk, and liquidity risk.

**Credit risk**

The Company's credit risk is primarily attributable to trade receivables. Trade receivables comprise amounts due from other businesses from the sale of groceries and dry goods. The Company mitigates credit risk through approvals, limits and monitoring. The amounts disclosed in the consolidated balance sheet are net of allowances for expected credit losses, estimated by the Company's management based on past experience and specific circumstances of the customer. The Company manages credit risk for cash by placing deposits at major Canadian financial institutions.

**Market risk** 

Market risk is the risk that changes in market prices and interest rates will affect the Company's net earnings or the value of financial instruments. These risks are generally outside the control of the Company. The objective of the Company is to mitigate market risk exposures within acceptable limits, while maximizing returns. The Company's market risk consists of risks from changes in foreign exchange rates, interest rates and market prices that affect its financial liabilities, financial assets and future transactions.

Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 and Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on market risk.

**Foreign Exchange risk**

Our revenue is derived from operations in Canada. Our consolidated financial statements are presented in U.S. dollars and our liabilities other than trade payables are primarily due in U.S. dollars. The revenue we earn in Canadian dollars is adversely impacted by the increase in the value of the U.S. dollar relative to the Canadian dollar.

**Liquidity risk**

Liquidity risk relates to the risk the Company will encounter difficulty in meeting its obligations associated with financial liabilities. The financial liabilities on our consolidated balance sheets consist of accounts payable and accrued liabilities, due to related party, notes payable, convertible notes, net, derivative liabilities, promissory notes, promissory notes – related party and non-redeemable convertible notes, Management monitors cash flow requirements and future cash flow forecasts to ensure it has access to funds through its existing cash and from operations to meet operational and financial obligations

OUTSTANDING SHARE DATA

As of May 12, 2026, the following securities were outstanding:

Common stock 6,633,882,467 shares

OFF-BALANCE SHEET TRANSACTIONS

We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

**ITEM 4. CONTROLS AND PROCEDURES**

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending December 31, 2026, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2026 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS.**

We may be involved from time to time in ordinary litigation, negotiation and settlement matters that will not have a material effect on our operations or finances. We are not aware of any pending or threatened litigation against our Company or our officers and directors in their capacity as such that could have a material impact on our operations or finances.

**ITEM 1A. RISK FACTORS**

A smaller reporting company is not required to provide the information required by this Item.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**

Not applicable.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES.**

During the quarter ended March 31, 2026, we did not have any defaults upon senior securities.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION.**

During the quarter ended March 31, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.

**ITEM 6. EXHIBITS**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | &nbsp;&nbsp;Incorporated by reference | &nbsp;&nbsp;Incorporated by reference | &nbsp;&nbsp;Incorporated by reference | &nbsp;&nbsp;Incorporated by reference |
| &nbsp;&nbsp;Exhibit | &nbsp;&nbsp;Exhibit Description | &nbsp;&nbsp;Filed herewith | &nbsp;&nbsp;Form | &nbsp;&nbsp;Period ending | &nbsp;&nbsp;Exhibit | &nbsp;&nbsp;Filing date |
| &nbsp;&nbsp;[3.1](http://www.sec.gov/Archives/edgar/data/1494413/000149441310000003/ipo_s1june222010ex31.txt) | &nbsp;&nbsp;Certificate of Incorporation, dated April 3, 2009 |  | &nbsp;&nbsp;S-1 |  | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;6/22/2010 |
| &nbsp;&nbsp;[3.2](http://www.sec.gov/Archives/edgar/data/1494413/000149441310000003/ipo_s1june222010ex32.txt) | &nbsp;&nbsp;Bylaws, dated April 3, 2009 |  | &nbsp;&nbsp;S-1 |  | &nbsp;&nbsp;3.2 | &nbsp;&nbsp;6/22/2010 |
| &nbsp;&nbsp;[3.3](http://www.sec.gov/Archives/edgar/data/1494413/000149441313000009/ipo_08082013_certofamendment.txt) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated August 8, 2013 |  | &nbsp;&nbsp;10-Q | &nbsp;&nbsp;6/30/2013 | &nbsp;&nbsp;3.3 | &nbsp;&nbsp;8/14/2013 |
| &nbsp;&nbsp;[3.4](http://www.sec.gov/Archives/edgar/data/1494413/000126246316001024/ex31.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated July 27, 2016 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;9/1/2016 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;9/1/2016 |
| &nbsp;&nbsp;[3.5](http://www.sec.gov/Archives/edgar/data/0001494413/000126246318000275/ex31.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated August 27, 2018 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;9/10/2018 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;9/10/2018 |
| &nbsp;&nbsp;[3.6](http://www.sec.gov/Archives/edgar/data/0001494413/000126246319000426/ex31.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated November 18, 2019 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;12/12/2019 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;12/12/2019 |
| &nbsp;&nbsp;[3.7](http://www.sec.gov/Archives/edgar/data/0001494413/000126246321000330/ex3.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated July 16, 2021 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;7/16/2021 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;7/22/2021 |
| &nbsp;&nbsp;[3.8](http://www.sec.gov/Archives/edgar/data/0001494413/000126246322000009/ex3.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, dated January 3, 2022 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;1/3/2022 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;1/6/2022 |
| &nbsp;&nbsp;[3.9](http://www.sec.gov/Archives/edgar/data/0001494413/000126246322000066/ex3.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, As Amended, dated<br> March 21, 2022 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;4/25/2022 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;4/26/2022 |
| &nbsp;&nbsp;[3.10](https://www.sec.gov/Archives/edgar/data/1494413/000126246323000084/twoh8krs_92023.htm) | &nbsp;&nbsp;Certificate of Amendment to the Certificate of Incorporation, As Amended, filed with the Delaware Secretary of State on August 22, 2023. |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;9/8/2023 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;9/11/2023 |
| &nbsp;&nbsp;[4.1](http://www.sec.gov/Archives/edgar/data/1494413/000149441310000003/ipo_s1june222010ex41.txt) | &nbsp;&nbsp;Specimen Stock Certificate |  | &nbsp;&nbsp;S-1 |  | &nbsp;&nbsp;4.1 | &nbsp;&nbsp;6/22/2010 |
| &nbsp;&nbsp;[4.2](http://www.sec.gov/Archives/edgar/data/1494413/000149441313000009/ipo_08062013_certofdesintn.txt) | &nbsp;&nbsp;Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, dated August 6, 2013 |  | &nbsp;&nbsp;10-Q | &nbsp;&nbsp;6/30/2013 | &nbsp;&nbsp;4.2 | &nbsp;&nbsp;8/14/2013 |
| &nbsp;&nbsp;[4.3](http://www.sec.gov/Archives/edgar/data/0001494413/000126246319000435/ex31.htm) | &nbsp;&nbsp;Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, dated December 12, 2019 |  | &nbsp;&nbsp;8-K<br>| &nbsp;&nbsp;12/12/2019<br>| &nbsp;&nbsp;3.1<br>| &nbsp;&nbsp;12/19/2019<br>|
| &nbsp;&nbsp;[4.4](http://www.sec.gov/Archives/edgar/data/0001494413/000126246320000396/ex3.htm) | &nbsp;&nbsp;Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated October 7, 2020 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;10/07/2020 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;10/08/2020 |
| &nbsp;&nbsp;[4.5](http://www.sec.gov/Archives/edgar/data/0001494413/000126246321000307/ex3.htm) | &nbsp;&nbsp;Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated June 24, 2021 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;6/24/2021 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;7/1/2021 |
| &nbsp;&nbsp;[4.6](http://www.sec.gov/Archives/edgar/data/0001494413/000126246321000426/ex31.htm) | &nbsp;&nbsp;Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock, dated September 1, 2021 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;9/1/2021 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;9/1/2021 |
| &nbsp;&nbsp;[4.7](http://www.sec.gov/Archives/edgar/data/0001494413/000126246322000069/ex3.htm) | &nbsp;&nbsp;Amended and Restated Designation of Series A Convertible Preferred Stock of Two Hands Corporation, dated April 21, 2022 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;4/21/2022 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;4/26/2022 |
| &nbsp;&nbsp;[4.8](https://www.sec.gov/Archives/edgar/data/1494413/000126246322000114/ex4.htm) | &nbsp;&nbsp;Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated July 5, 2022 |  | &nbsp;&nbsp;10-Q | &nbsp;&nbsp; 6/30/2022 | &nbsp;&nbsp; 4.8 | &nbsp;&nbsp;8/15/2022 |
| &nbsp;&nbsp;[4.9](https://www.sec.gov/Archives/edgar/data/1494413/000126246322000127/ex31.htm) | &nbsp;&nbsp;Certificate of Designation, Preference and Rights of Series E Preferred Stock, dated October 3, 2022 |  | &nbsp;&nbsp;8-K | &nbsp;&nbsp;10/4/2022 | &nbsp;&nbsp;3.1 | &nbsp;&nbsp;10/11/2022 |
| &nbsp;&nbsp;[10.1](http://www.sec.gov/Archives/edgar/data/1494413/000149441310000003/ipo_s1june222010ex101.txt) | &nbsp;&nbsp;Innovative Product Opportunities Inc. Trust Agreement |  | &nbsp;&nbsp;S-1 |  | &nbsp;&nbsp;10.1 | &nbsp;&nbsp;6/22/2010 |
| &nbsp;&nbsp;[10.2](http://www.sec.gov/Archives/edgar/data/1494413/000151116418000188/f102.htm) | &nbsp;&nbsp;Side Letter Agreement, The Cellular Connection Ltd., dated January 8, 2018 |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2017 | &nbsp;&nbsp;10.2 | &nbsp;&nbsp;3/29/2018 |
| &nbsp;&nbsp;[10.3](http://www.sec.gov/Archives/edgar/data/1494413/000151116418000188/f103.htm) | &nbsp;&nbsp;Side Letter Agreement, Stuart Turk, dated January 8, 2018 |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2017 | &nbsp;&nbsp;10.3 | &nbsp;&nbsp;3/29/2018 |
| &nbsp;&nbsp;[10.4](http://www.sec.gov/Archives/edgar/data/1494413/000151116418000344/exhibit104.htm) | &nbsp;&nbsp;Side Letter Agreement, Jordan Turk, dated April 12, 2018 |  | &nbsp;&nbsp;10-Q | &nbsp;&nbsp;3/31/2018 | &nbsp;&nbsp;10.4 | &nbsp;&nbsp;5/21/2018 |
| &nbsp;&nbsp;[10.5](http://www.sec.gov/Archives/edgar/data/1494413/000151116418000344/exhibit105.htm) | &nbsp;&nbsp;Side Letter Agreement, Jordan Turk, dated May 10, 2018 |  | &nbsp;&nbsp;10-Q | &nbsp;&nbsp;3/31/2018 | &nbsp;&nbsp;10.5 | &nbsp;&nbsp;5/21/2018 |
| &nbsp;&nbsp;[10.6](http://www.sec.gov/Archives/edgar/data/1494413/000126246319000085/ex106.htm) | &nbsp;&nbsp;Side Letter Agreement, Jordan Turk, dated September 13, 2018 |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2018<br>| &nbsp;&nbsp;10.6 | &nbsp;&nbsp;4/1/2019 |
| &nbsp;&nbsp;[10.7](http://www.sec.gov/Archives/edgar/data/1494413/000126246319000085/ex107.htm) | &nbsp;&nbsp;Side Letter Agreement, The Cellular Connection Ltd., dated January 31, 2019 |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2018 | &nbsp;&nbsp;10.7 | &nbsp;&nbsp;4/1/2019 |
| &nbsp;&nbsp;[10.8](http://www.sec.gov/Archives/edgar/data/1494413/000126246319000085/ex108.htm) | &nbsp;&nbsp;Side Letter Agreement, Stuart Turk, dated January 31, 2019 |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2018 | &nbsp;&nbsp;10.8 | &nbsp;&nbsp;4/1/2019 |
| &nbsp;&nbsp;[19.1](https://www.sec.gov/Archives/edgar/data/1494413/000126246325000100/ex19.htm) | &nbsp;&nbsp;Insider Trading Policy |  | &nbsp;&nbsp;10-K | &nbsp;&nbsp;12/31/2024 | &nbsp;&nbsp; 19.1 | &nbsp;&nbsp; 4/14/2025 |
| &nbsp;&nbsp;[31.1](ex311.htm) | &nbsp;&nbsp;Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;[31.2](ex312.htm) | &nbsp;&nbsp;Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;[32.1](ex321.htm)\* | &nbsp;&nbsp;Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;[32.2](ex322.htm)\* | &nbsp;&nbsp;Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.INS | &nbsp;&nbsp;XBRL Instance Document – the instance document does not appear in the Interactive Data Files as its XBRL tags are embedded within the Inline XBRL document | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.SCH | &nbsp;&nbsp;XBRL Taxonomy Extension Schema Document | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.CAL | &nbsp;&nbsp;XBRL Taxonomy Extension Calculation Linkbase Document | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.LAB | &nbsp;&nbsp;XBRL Taxonomy Extension Label Linkbase Document | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.PRE | &nbsp;&nbsp;XBRL Taxonomy Extension Presentation Linkbase Document | &nbsp;&nbsp;X |  |  |  |  |
| &nbsp;&nbsp;101.DEF | &nbsp;&nbsp;XBRL Taxonomy Extension Definition Linkbase Definition | &nbsp;&nbsp;X |  |  |  |  |
| 104 | &nbsp;&nbsp;Cover page formatted as Inline XBRL and contained in Exhibit 101 | &nbsp;&nbsp;X |  |  |  |  |

---

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under those sections.

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;**TWO HANDS CORPORATION** |
| &nbsp;&nbsp;Dated: May 22, 2026 | &nbsp;&nbsp; By: *<u>/s/ Emil Assentato</u>*<br> Name: Emil Assentato<br> Title: President, Chief Executive Officer and Director<br> (Principal Executive Officer) |
|  | &nbsp;&nbsp; By: <u>/s/ *Matthew Stark*</u><br> Name: Matthew Stark<br> Title: Chief Financial Officer and Director<br> (Principal Financial and Accounting Officer) |

---

## Ex-31

**EXHIBIT 31.1**

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Emil Assentato, certify that:

1. I have reviewed this Form 10-Q of Two Hands Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the

periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing for establishing and maintaining

disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over

financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed

under our supervision, to ensure that material information relating to the registrant, including its consolidated

subsidiaries, is made known to us by others within those entities, particularly during the period in which this report

is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be

designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and

the preparation of financial statements for external purposes in accordance with generally accepted accounting

principles,

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our

conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by

this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during

the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that

has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial

reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or

persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial

reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and

report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

May 22, 2026

*<u>/s/ Emil Assentato</u>*

Emil Assentato

Chief Executive Officer

(Principal Executive Officer)

## Ex-31

**EXHIBIT 31.2**

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Matthew Stark, certify that:

1. I have reviewed this Form 10-Q of Two Hands Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements were made,

not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the

periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing for establishing and maintaining

disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over

financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed

under our supervision, to ensure that material information relating to the registrant, including its consolidated

subsidiaries, is made known to us by others within those entities, particularly during the period in which this report

is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be

designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and

the preparation of financial statements for external purposes in accordance with generally accepted accounting

principles,

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our

conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by

this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during

the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that

has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial

reporting.

5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or

persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial

reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and

report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the

registrant's internal control over financial reporting.

May 22, 2026

*<u>/s/ Matthew Stark</u>*

Matthew Stark

Chief Financial Officer

(Principal Financial and Accounting Officer)

## Ex-32

**EXHIBIT 32.1**

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Two Hands Corporation (the "Company") on Form 10-Q for the period ended March 31, 2026, as filed with the Securities and Exchange Commission (the "Report"), I, Emil Assentato, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

May 22, 2026

*<u>/s/ Emil Assentato</u>*

Emil Assentato

Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been

provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or

its staff upon request.

## Ex-32

**EXHIBIT 32.2**

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Two Hands Corporation (the "Company") on Form 10-Q for the period ended March 31, 2026, as filed with the Securities and Exchange Commission (the "Report"), I, Matthew Stark, Treasurer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;May 22, 2026

*<u>/s/ Matthew Stark</u>*

Matthew Stark

Chief Financial Officer

(Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or

otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been

provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or

its staff upon request.